In accordance with the in vitro results, exogenous Irisin treatment could promote autophagy and reduce ROS accumulation and the activation of NLRP3-mediated pyroptosis signaling in the aortas of CKD mice. This evidence concerns the gene NLRP3 and chronic kidney disease.